On 6th and 7th of December, We participated in “Digital Pathology & AI Congress” in London where the Christmas atmosphere prevailed everywhere. The meeting has covered new areas . . .
We were proud to join one of the biggest startup events “Slush 2018” in Helsinki as a part of “Startup Team Fukuoka” along with the City of Fukuoka . . .
It is a Pathological Image Diagnosis software which relies on AI to achieve smart analysis, then produce a highly accurate result. We use Deep Learning . . .
On the stage, Osamu had discussed the topic of AI×Business with Mr. Katsumasa Niki, CEO of DEEPCORE, and Ms. Ayaka Ikezawa, the entertainer/engineer. During the discussion, Mr. Niki . . .
The news of our investment has published in TechCrunch. https://jp.techcrunch.com/2018/08/17/medmain-fundraising/
Medmain Inc. (Fukuoka City, CEO:Osamu Iizuka) has raised ¥100million from DEEPCORE, the AI specialized VC, and DOGANβ, the Kyushu-district specialized VC. Medmain is currently developing “PidPort”, the software . . .
Marketing/Building new teams Marketing (Strategy, Design, Practice） ・Planning and Management works to brush up “Medteria”, the tailored cloud service for medical students. ・Marketing tasks . . .
The annual meeting of Japanese Society of Pathology was held in Sapporo City from 21st to 23rd of June. Through the meeting, we have realized that pathologists in . . .
On 6th June, Osamu Iizuka had been invited to Prime Minister of Japan and His cabinet, and presented about Medmain in front of Prime Minister of Japan, Mr.Sinzo . . .
Osamu Iizuka (CEO) has joined the conference with Juli Ratas, The Prime Minister of Estonia, along with Soichiro Takashima, the Mayor of Fukuoka City, and so on. Though . . .